SCHEDULE: LeMaitre Vascular: George W. LeMaitre Reports 6.4% Stake

Sentiment:

Beneficial Ownership Filing


George W. LeMaitre has filed a Schedule 13G, reporting beneficial ownership of 1,465,235 shares of LeMaitre Vascular, Inc. common stock, representing 6.4% of the outstanding shares.

Summary

  • George W. LeMaitre has filed an amendment to Schedule 13G, indicating his beneficial ownership of LeMaitre Vascular, Inc. common stock.
  • As of March 31, 2026, Mr. LeMaitre beneficially owns 1,465,235 shares.
  • This ownership represents 6.4% of the company's common stock outstanding.
  • The filing is an amendment to a previous filing, with this update reflecting the ownership as of March 31, 2026.
  • The reported shares include 6,847 shares subject to options exercisable within 60 days of March 31, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not contain new financial performance data or strategic announcements.

Positives

  • George W. LeMaitre maintains a significant ownership stake of 6.4% in LeMaitre Vascular, Inc., indicating continued confidence or investment.
  • The filing is an update, suggesting ongoing monitoring and reporting of ownership by a key individual.
  • The inclusion of exercisable options in the beneficial ownership calculation provides a more comprehensive view of potential control.

Future Outlook

No specific forward-looking statements or guidance are provided in this Schedule 13G filing.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual shareholders to report their stakes in publicly traded companies. This filing by George W. LeMaitre confirms his substantial interest in LeMaitre Vascular, Inc., a company operating in the medical device sector.

Stakeholder Impact

  • Shareholders: The filing confirms a significant individual shareholder's stake, which can be a factor in market perception and potential influence on corporate decisions.
  • Management: The continued significant ownership by George W. LeMaitre may imply a stable or influential role in the company's governance.

Key Dates

DateDescription
03/31/2026Date of Event Which Requires Filing of this Statement / Reporting Date for Ownership
05/14/2026Date of Signature on the Filing

Keywords

LeMaitre Vascular, Schedule 13G, Beneficial Ownership, SEC Filing, Common Stock, George W. LeMaitre, Ownership Stake

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.